Regulus Therapeutics | RGLS - Spese Operative



Spese Operative Cambiamento Data
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Biogen USD 1.88B 81.4M 2025-09
Celldex Therapeutics USD 87.27M 511.09M 2025-12
Cipla INR 60.98B 1.06B 2025-12
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.29M 1.51M 2025-12
CSL USD 5.7B 2.82B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Immunic USD 25.73M 2.91M 2024-09
Incyte USD 1.12B 3.53B 2025-12
Intrexon USD 61.56M 26.1M 2024-06
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
Merck USD 10.16B 558M 2025-12
Omeros USD 59.16M 20.13M 2024-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sanofi EUR 10.71B 1.32B 2025-12
Takeda JPY 1.02T 400.98B 2025-12